Article
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
Nature genetics - 1 Oct 2009
Tanaka Yasuhito, Nishida Nao, Sugiyama Masaya, Kurosaki Masayuki, Matsuura Kentaro, Sakamoto Naoya, Nakagawa Mina, Korenaga Masaaki, Hino Keisuke, Hige Shuhei, Ito Yoshito, Mita Eiji, Tanaka Eiji, Mochida Satoshi, Murawaki Yoshikazu, Honda Masao, Sakai Akito, Hiasa Yoichi, Nishiguchi Shuhei, Koike Asako, Sakaida Isao, Imamura Masatoshi, Ito Kiyoaki, Yano Koji, Masaki Naohiko, Sugauchi Fuminaka, Izumi Namiki, Tokunaga Katsushi, Mizokami Masashi
Abstract excerpt
The recommended treatment for patients with chronic hepatitis C, pegylated interferon-alpha (PEG-IFN-alpha) plus ribavirin (RBV), does not provide sustained virologic response (SVR) in all patients. We report a genome-wide association study (GWAS) to null virological response (NVR) in the treatment of patients with hepatitis C virus (HCV) genotype 1 within a Japanese population. We found two SNPs near the gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
